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Background: Corneal ulcers often lead to scarring and astigmatism, and significant loss of 
vision is a common consequence.
Objective: To determine the rate of graft rejection, one of the most serious concerns with 
this procedure, and to evaluate the recovery of visual function in those patients for whom the 
operation was successful.
Methods: We describe a retrospective study of 33 corneal ulcer patients undergoing penetrating 
keratoplasty (PK) at the Tabriz Nikookari Eye Hospital.
Results: Mean age of the patients was 44 ± 14 years. Most common risk factors for active 
  keratitis were trauma, dry eye, and malnutrition. Culture-positive results included bacterial 
  keratitis (n = 15) and fungal keratitis (n = 5). Perforation was a significant risk factor for 
  therapeutic failure (P , 0.05). Age or gender had no statistically significant effects on the PK 
outcome (P . 0.05). Postoperative visual acuity had a significant association with preoperative 
visual acuity (P , 0.01). Graft rejection rate (27.2%) was similar to that reported in the 
literature.
Conclusion: Although lamellar keratoplasty has recently been established, there are practical 
reasons for continuing the use of PK in centers such as ours, with due attention to the requirement 
for topical immunosuppression to diminish the rate of graft rejection and antimicrobial treatment 
to prevent postoperative infection.
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Introduction
Corneal ulcers often lead to scarring and astigmatism, and significant loss of vision 
is a common consequence. In severe cases, perforation, scleral involvement, and 
endophthalmitis may occur. Corneal ulcer together with ocular trauma are the major 
causes of blindness in developing countries.1 Different types of ulcers result from 
different pathological processes and require different management approaches.2 
Keratitis is usually caused by bacteria and fungi.3,4 Recently, fungal causation associated 
with soft contact lens use has become an increasing cause of concern.5 Chemical burns 
by strong acids or alkalis are relatively prevalent among young patients.6
If corneal perforation seems likely, urgent management is required, since corneal 
perforation has high morbidity,7 and keratoplasty is a common procedure.2 Amniotic 
membrane transplantation has proved successful as an adjunctive method for corneal 
re-epithelization,3,8 but has not replaced keratoplasty, partly because of availability of 
donor tissue. Penetrating keratoplasty (PK) is a well established technique; however, long-
recognized complications such as postoperative infection, corneal and macular edema, Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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astigmatism, retinal detachment, and high rates of immune 
reactions and graft failure remain significant concerns.9–15
In this paper we describe a retrospective study of patients 
with corneal ulcer with or without serious vision loss who 
had undergone PK at Tabriz Nikookari Eye Hospital. Our 
aim was to determine the rate of graft rejection, one of the 
most serious concerns with this procedure, and to evaluate 
the recovery of visual function in those patients for whom 
the operation was successful.
Methods
Thirty-three patients aged between 5 and 80 years who 
underwent PK because of corneal ulcer in Tabriz Nikookari 
Eye Hospital between 2000 and 2003 were retrospectively 
evaluated.16,17 The indications for PK were recurrent or 
unhealing corneal ulcer (n = 8, 24.2%) or perforation 
(n = 25, 75.7%). The age, gender, etiology of corneal 
ulcer, and associated diseases were recorded for each 
patient.18,19 Post-PK follow-up period ranged from 3 to 
24 months (mean = 11.6 months). On presentation and at 
time of PK, corneal scrapings were cultured to identify 
the organisms. Therapeutic success was defined as com-
plete eradication of infection after PK with appropriate 
adjunctive medical therapy. Therapeutic failure was 
defined as recurrent corneal infection that progressed to 
endophthalmitis or phthisis bulbi despite medical therapy 
requiring evisceration.
Patients diagnosed with bacterial keratitis received 
appropriate antibiotics in culture-positive cases. In 
culture-negative cases, two broad-spectrum topical antibiotics 
were prescribed; gentamicin (14 mg/mL) and cefazolin 
(50 mg/mL) alternately every 10 minutes for the first hour 
then hourly for the next 24–48 hours, then tapering gradually 
according to the treatment response. Oral or intravenous 
antibiotics such as ciprofloxacin and ceftazidime were 
prescribed when the infiltrate encroached the limbus or 
if perforation was present or deemed impending. Patients 
with fungal keratitis received hourly topical amphotericin 
B 0.1% and natamycin 5%. In addition, patients with 
suspected anterior chamber (AC) or scleral involvement 
received preoperative oral ketoconazole 400 mg daily for 
1–4 weeks. For bacterial keratitis, topical steroids generally 
were commenced only 1–5 days after surgery. For fungal 
keratitis, topical steroids use was on average delayed by 
1–3 weeks, whereas amphotericin B 0.1% and natamycin 
5% were tapered over 8–12 weeks. Postoperative oral 
ketoconazole was prescribed in all patients with perforation, 
when infection had breached the AC through suture tracks 
or previous surgical wounds, and in patients with obvious 
limbal or scleral extension, particularly if culture results 
showed Candida or Aspergillus species.
Data were recorded as mean ± SD or frequency, as 
appropriate, and were compared using Student’s t-test or a 
chi-square test using SPSS for Windows (v 11.5; SPSS, Inc, 
Chicago, IL). A P value , 0.05 was considered statistically 
significant.
Results
Thirty-three patients, 23 males and ten females, were enrolled 
in the present study. Mean age of patients was 44 ± 14 years 
(range: 5–80 years). The major risk factors for active keratitis 
were trauma (n = 5), dry eye (n = 4), malnutrition (n = 4), 
previous eye surgery (n = 3), and chemical burn (n = 3). 
Figures 1 and 2 show preoperative and postoperative images 
of the corneal ulcers, respectively. Postoperatively, visual 
acuity improved in 24 patients (72.7%) and high astigmatism 
occurred in 14 (35%), but there was no association with age 
or gender in either case (P . 0.1).
Culture-positive results included bacterial keratitis 
(n = 15) and fungal keratitis (n = 5). The most common 
isolated bacterium and fungus were Staphylococcus 
epidermidis (n = 10), and Fusarium species (n = 2). Thirteen 
patients had culture-negative results; the clinical appearance 
in eleven patients strongly resembled that of bacterial 
keratitis and they received treatment accordingly. Among 
these culture-negative patients, two therapeutic failures 
occurred.
Figure 1 Corneal ulcer before the penetrating keratoplasty.Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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Twenty-seven patients (81.8%) achieved therapeutic 
success. Therapeutic failure occurred in 4 eyes with limbal 
extension and two eyes with perforated ulcer. Three eyes 
had fungal keratitis. Infection recurrence time varied from 
4 days to 1 year, most recurrences (n = 4)   appearing within 
6 weeks of surgery. Possible risk factors for failure were 
analyzed. Perforation was a significant risk factor (P , 0.05), 
but limbal extension was not shown to be a definite predictor 
for therapeutic failure (P . 0.05) in our cases.
General complications included endothelial   rejection 
(n = 9), glaucoma (n = 7), and phthisis bulbi (n = 2). 
  Glaucoma was controlled by medication. Rejection was 
reversed in six eyes, whereas three cases of rejection resulted 
in late graft failure. Graft rejection presented as photophobia, 
eye redness, visual blurring, and pain, in descending order 
of frequency. Age or gender had no statistically significant 
effects on PK outcome (P = 0.447 and 0.715, respectively). 
Five patients underwent simultaneous cataract surgery. 
Postoperative visual acuity had a significant association with 
preoperative visual acuity (P , 0.01).
Discussion
Our corneal ulcer patients covered a wide age and gender 
range. Therefore, our finding that age and gender had no 
significant influence on our outcome measures could be 
generally valid. For those patients in whom the graft was not 
rejected, visual function markedly improved, supporting the 
view that PK is a valuable procedure for patients with corneal 
ulcer in spite of the associated risks. The graft rejection rate 
(27.2% of the total cohort) is broadly consistent with values 
in the literature.20–22
The immune reaction associated with microbial kera-
titis and corneal transplant rejection has been studied in 
detail and was reviewed by Dana et al.23 Essentially, local 
Langerhans cells and other antigen-presenting cells are 
activated, pro-inflammatory cytokines such as interleukin-1 
and tumor necrosis factor-α are upregulated, and a range 
of immune functions ensues, resulting in the recruitment 
of neutrophils and T helper type 1 lymphocytes and matrix 
metalloproteinase activation. The consequences can entail 
considerable corneal injury. Systemic immunosuppressants 
are not recommended for PK patients, but topical steroids 
supplemented with agents such as cyclosporine have been 
shown to be effective in reducing allograft rejection rates and 
should be considered.24–26
Recent advances in lamellar keratoplasty accompanied by 
antimicrobial treatment have also improved the success rate in 
terms of visual function and infection.27 It is less invasive than 
PK and vision is recovered more rapidly after the operation, 
and since long-term corneal sutures are not required, the 
problems associated with such sutures are eliminated. On 
the other hand, there is an absolute requirement for specially 
prepared donor tissue and surgeons with specific training or 
experience with the technique. In centers such as ours, these 
are currently not options. Therefore, with due attention to the 
need for topical immunosuppression and treatment to combat 
postoperative infection, there is a strong case for continuing 
the use of PK for corneal ulcer patients.
In summary, although the mainstay of initial management 
of severe infective keratitis remains aggressive antimicrobial 
therapy to limit spread to the sclera and AC, the role of 
timely surgical intervention in the form of therapeutic 
keratoplasty should be considered in view of the relatively 
successful outcomes in our series of patients with severe, 
end-stage disease. The timing of surgery is critical for good 
therapeutic outcomes, which we believe may be enhanced 
by earlier rather than later intervention, because scleral or 
intraocular extension of infection is likely to result in poorer 
outcomes.
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